Caribou Biosciences Initiates the CB-010 GALLOP Phase 1 Trial in Lupus and Provides Outlook for Multiple Clinical Datasets in 2025
NDAQ:CRBU) Caribou Biosciences Initiates the CB-010 GALLOP Phase 1 Trial in Lupus and Provides Outlook for Multiple Clinical Datasets in 2025 ...
WuXi AppTec Joins the Pharmaceutical Supply Chain Initiative (PSCI)
WuXi AppTec, a global company that provides a broad portfolio of R&D and manufacturing services to enable companies in the pharmaceutical and life sciences industries, announced that it has joined the ...
Exact Sciences Announces Preliminary Fourth Quarter 2024 Results
Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that the company expects to report revenue of $713 million for the fourth quarter ...
Visa Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - V
NYSE:V) Visa Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - V ...
Telix to Acquire Next-Generation Therapeutic Assets and Innovative Biologics Technology Platform
Following closing of its transaction with Telix Pharmaceuticals, ImaginAb, Inc. will be focused on developing its lead imaging candidate, CD8 ImmunoPET, which is currently in Phase 2 clinical trials ...
CRBU Investors Have Opportunity to Lead Caribou Biosciences, Inc. Securities Fraud Lawsuit
NEW YORK, Jan. 12, 2025 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Caribou Biosciences, Inc. (NASDAQ: CRBU) between July 14, 2023 and July ...
Vertex Provides Pipeline and Business Updates in Advance of Upcoming Investor Meetings
A live webcast of management's remarks will be available through the Vertex website, www.vrtx.com, in the "Investors" section under the "News and Events" page. A replay of the conference webcast will ...
Ascendis Pharma Provides Business and Strategic Roadmap Update at 43rd Annual J.P. Morgan Healthcare Conference
NDAQ:ASND) Ascendis Pharma Provides Business and Strategic Roadmap Update at 43rd Annual J.P. Morgan Healthcare Conference ...
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Match Group, Inc.(MTCH) Shareholders
NDAQ:MTCH) Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Match Group, Inc.(MTCH) Shareholders ...
CPRI Investors Have Opportunity to Lead Capri Holdings Limited Securities Fraud Lawsuit
To join the Capri Holdings class action, go to https://rosenlegal.com/submit-form/?case_id=33109 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the ...
Caribou Biosciences, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - CRBU
NDAQ:CRBU) Caribou Biosciences, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - CRBU ...